Characterization of the ubiquitylating components of the human malaria parasite's protein degradation pathway

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Chung, Duk Won D ^a   Ponts, Nadia ^a,b   Prudhomme, Jacques ^a   Rodrigues, Elisandra M ^a   Le Roch, Karine G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

E1 UBIQUITIN ACTIVATING ENZYME; PROTEASOME; PROTEASOME INHIBITOR; UBIQUITIN CONJUGATING ENZYME E2; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E1; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; CYTOSOL; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; ENZYME LOCALIZATION; GENE DISRUPTION; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE SURVIVAL; PLASMODIUM; PROTEIN TARGETING; UBIQUITINATION;

AMINO ACID SEQUENCE; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION; HOST-PARASITE INTERACTIONS; HUMANS; HYDRAZONES; HYDROXYUREA; IMMUNOBLOTTING; MALARIA; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; PROTEOLYSIS; PROTOZOAN PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATED PROTEINS; UBIQUITINATION;

EID: 84865077268     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043477     Document Type: Article

References (48)

1. Garcia LS, ((2010)) Malaria. Clinics in Laboratory Medicine 30:: 93--129 doi:10.1016/j.cll.2009.10.001.
2. van Vugt M, van Beest A, Sicuri E, van Tulder M, Grobusch MP, ((2011)) Malaria treatment and prophylaxis in endemic and nonendemic countries: evidence on strategies and their cost-effectiveness. Future Microbiol 6:: 1485--1500 doi:10.2217/fmb.11.138.
3. Lindenthal C, Weich N, Chia YS, Heussler V, Klinkert MQ, ((2005)) The proteasome inhibitor MLN-273 blocks exoerythrocytic and erythrocytic development of Plasmodium parasites. Parasitology 131:: 37--44.
4. Reynolds JM, El Bissati K, Brandenburg J, Günzl A, Mamoun CB (n.d.) Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL3B. BMC Clin Pharmacol 7:: 13--13 doi:10.1186/1472-6904-7-13.
5. Dick LR, Cruikshank AA, Grenier L, Melandri FD, Nunes SL, et al. ((1996)) Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin beta-lactone. J Biol Chem 271:: 7273--7276.
6. Kreidenweiss A, Kremsner PG, Mordmüller B (n.d.) Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon. Malar J 7:: 187--187 doi:10.1186/1475-2875-7-187.
7. Prudhomme J, McDaniel E, Ponts N, Bertani S, Fenical W, et al. (2008) Marine Actinomycetes: A New Source of Compounds against the Human Malaria Parasite. PLoS ONE 3. doi:10.1371/journal.pone.0002335.
8. Chung D-WD, Le Roch KG, ((2010)) Targeting the Plasmodium ubiquitin/proteasome system with anti-malarial compounds: promises for the future. Infect Disord Drug Targets 10:: 158--164.
9. Li GD, Li JL, Mugthin M, Ward SA, ((2000)) Molecular cloning of a gene encoding a 20S proteasome beta subunit from Plasmodium falciparum. Int J Parasitol 30:: 729--733.
10. Certad G, Abrahem A, Georges E, ((1999)) Cloning and partial characterization of the proteasome S4 ATPase from Plasmodium falciparum. Exp Parasitol 93:: 123--131 doi:10.1006/expr.1999.4442.
11. Ramasamy G, Gupta D, Mohmmed A, Chauhan VS, ((2007)) Characterization and localization of Plasmodium falciparum homolog of prokaryotic ClpQ/HslV protease. Mol Biochem Parasitol 152:: 139--148 doi:10.1016/j.molbiopara.2007.01.002.
12. Yoo SJ, Seol JH, Shin DH, Rohrwild M, Kang MS, et al. ((1996)) Purification and characterization of the heat shock proteins HslV and HslU that form a new ATP-dependent protease in Escherichia coli. J Biol Chem 271:: 14035--14040.
13. Gardner MJ, Hall N, Fung E, White O, Berriman M, et al. ((2002)) Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419:: 498--511 doi:10.1038/nature01097.
14. Xie W, Ng DTW, ((2010)) ERAD substrate recognition in budding yeast. Seminars in Cell & Developmental Biology 21:: 533--539 doi:16/j.semcdb.2010.02.007.
15. Sato BK, Schulz D, Do PH, Hampton RY, ((2009)) Misfolded Membrane Proteins Are Specifically Recognized by the Transmembrane Domain of the Hrd1p Ubiquitin Ligase. Molecular Cell 34:: 212--222 doi:16/j.molcel.2009.03.010.
16. Bagola K, Mehnert M, Jarosch E, Sommer T, ((2011)) Protein dislocation from the ER. Biochim Biophys Acta 1808:: 925--936 doi:10.1016/j.bbamem.2010.06.025.
17. Carvalho P, Goder V, Rapoport TA, ((2006)) Distinct Ubiquitin-Ligase Complexes Define Convergent Pathways for the Degradation of ER Proteins. Cell 126:: 361--373 doi:10.1016/j.cell.2006.05.043.
18. Hershko A, Ciechanover A, ((1998)) THE UBIQUITIN SYSTEM. Annu Rev Biochem 67:: 425--479 doi:10.1146/annurev.biochem.67.1.425.
19. Pickart CM, ((2004)) Back to the Future with Ubiquitin. Cell 116:: 181--190 doi:10.1016/S0092-8674(03)01074-2.
20. Laney JD, Hochstrasser M, ((1999)) Substrate Targeting in the Ubiquitin System. Cell 97:: 427--430 doi:10.1016/S0092-8674(00)80752-7.
21. Ponts N, Yang J, Chung D-WD, Prudhomme J, Girke T, et al. ((2008)) Deciphering the Ubiquitin-Mediated Pathway in Apicomplexan Parasites: A Potential Strategy to Interfere with Parasite Virulence. PLoS ONE 3:: e2386 doi:10.1371/journal.pone.0002386.
22. Cross BCS, McKibbin C, Callan AC, Roboti P, Piacenti M, et al. ((2009)) Eeyarestatin I inhibits Sec61-mediated protein translocation at the endoplasmic reticulum. J Cell Sci 122:: 4393--4400 doi:10.1242/jcs.054494.
23. McKibbin C, Mares A, Piacenti M, Williams H, Roboti P, et al. ((2012)) Inhibition of protein translocation at the endoplasmic reticulum promotes activation of the unfolded protein response. Biochem J 442:: 639--648 doi:10.1042/BJ20111220.
24. Sommer MS, Gould SB, Lehmann P, Gruber A, Przyborski JM, et al. ((2007)) Der1-mediated Preprotein Import into the Periplastid Compartment of Chromalveolates? Mol Biol Evol 24:: 918--928 doi:10.1093/molbev/msm008.
25. Spork S, Hiss JA, Mandel K, Sommer M, Kooij TWA, et al. ((2009)) An Unusual ERAD-Like Complex Is Targeted to the Apicoplast of Plasmodium falciparum. Eukaryotic Cell 8:: 1134--1145 doi:10.1128/EC.00083-09.
26. Klemba M, Goldberg DE, ((2005)) Characterization of plasmepsin V, a membrane-bound aspartic protease homolog in the endoplasmic reticulum of Plasmodium falciparum. Mol Biochem Parasitol 143:: 183--191 doi:10.1016/j.molbiopara.2005.05.015.
27. Deshaies RJ, Joazeiro CAP, ((2009)) RING domain E3 ubiquitin ligases. Annu Rev Biochem 78:: 399--434 doi:10.1146/annurev.biochem.78.101807.093809.
28. Wenzel DM, Klevit RE, ((2012)) Following Ariadne's thread: a new perspective on RBR ubiquitin ligases. BMC Biol 10:: 24 doi:10.1186/1741-7007-10-24.
29. Smith MH, Ploegh HL, Weissman JS, ((2011)) Road to Ruin: Targeting Proteins for Degradation in the Endoplasmic Reticulum. Science 334:: 1086--1090 doi:10.1126/science.1209235.
30. Gardner RG, Swarbrick GM, Bays NW, Cronin SR, Wilhovsky S, et al. ((2000)) Endoplasmic Reticulum Degradation Requires Lumen to Cytosol Signaling Transmembrane Control of Hrd1p by Hrd3p. J Cell Biol 151:: 69--82 doi:10.1083/jcb.151.1.69.
31. Edelmann MJ, Nicholson B, Kessler BM, ((2011)) Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases. Expert Rev Mol Med 13:: e35 doi:10.1017/S1462399411002031.
32. Xu GW, Ali M, Wood TE, Wong D, Maclean N, et al. ((2010)) The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma. Blood 115:: 2251--2259 doi:10.1182/blood-2009-07-231191.
33. Saha MN, Jiang H, Jayakar J, Reece D, Branch DR, et al. ((2010)) MDM2 antagonist nutlin plus proteasome inhibitor velcade combination displays a synergistic anti-myeloma activity. Cancer Biol Ther 9:: 936--944.
34. Mueller B, Lilley BN, Ploegh HL, ((2006)) SEL1L, the homologue of yeast Hrd3p, is involved in protein dislocation from the mammalian ER. J Cell Biol 175:: 261--270 doi:10.1083/jcb.200605196.
35. St-Pierre P, Dang T, Joshi B, Nabi IR (2012) Peripheral Endoplasmic Reticulum Localization of Gp78 Ubiquitin Ligase Activity. Journal of Cell Science. Available: http://www.ncbi.nlm.nih.gov/pubmed/22328510. Accessed 6 April 2012.
36. Tcherpakov M, Delaunay A, Toth J, Kadoya T, Petroski MD, et al. ((2009)) Regulation of endoplasmic reticulum-associated degradation by RNF5-dependent ubiquitination of JNK-associated membrane protein (JAMP). J Biol Chem 284:: 12099--12109 doi:10.1074/jbc.M808222200.
37. Hassink G, Kikkert M, van Voorden S, Lee S-J, Spaapen R, et al. ((2005)) TEB4 is a C4HC3 RING finger-containing ubiquitin ligase of the endoplasmic reticulum. Biochem J 388:: 647--655 doi:10.1042/BJ20041241.
38. Stagg HR, Thomas M, van den Boomen D, Wiertz EJHJ, Drabkin HA, et al. ((2009)) The TRC8 E3 ligase ubiquitinates MHC class I molecules before dislocation from the ER. J Cell Biol 186:: 685--692 doi:10.1083/jcb.200906110.
39. Hempel F, Felsner G, Maier UG, ((2010)) New mechanistic insights into pre-protein transport across the second outermost plastid membrane of diatoms. Molecular Microbiology 76:: 793--801 doi:10.1111/j.1365-2958.2010.07142.x.
40. Hunter S, Apweiler R, Attwood TK, Bairoch A, Bateman A, et al. ((2009)) InterPro: the integrative protein signature database. Nucleic Acids Res 37:: D211--215 doi:10.1093/nar/gkn785.
41. Melén K, Krogh A, von Heijne G, ((2003)) Reliability measures for membrane protein topology prediction algorithms. J Mol Biol 327:: 735--744.
42. Bendtsen JD, Nielsen H, von Heijne G, Brunak S, ((2004)) Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 340:: 783--795 doi:10.1016/j.jmb.2004.05.028.
43. Edgar RC, ((2004)) MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 32:: 1792--1797 doi:10.1093/nar/gkh340.
44. Le Roch KG, Zhou Y, Blair PL, Grainger M, Moch JK, et al. ((2003)) Discovery of gene function by expression profiling of the malaria parasite life cycle. Science 301:: 1503--1508 doi:10.1126/science.1087025.
45. Deitsch K, Driskill C, Wellems T, ((2001)) Transformation of malaria parasites by the spontaneous uptake and expression of DNA from human erythrocytes. Nucleic Acids Res 29:: 850--853.
46. Fidock DA, Wellems TE, ((1997)) Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil. Proc Natl Acad Sci USA 94:: 10931--10936.
47. Maier AG, Braks JAM, Waters AP, Cowman AF, ((2006)) Negative selection using yeast cytosine deaminase/uracil phosphoribosyl transferase in Plasmodium falciparum for targeted gene deletion by double crossover recombination. Molecular and Biochemical Parasitology 150:: 118--121 doi:10.1016/j.molbiopara.2006.06.014.
48. Melikova M, Kondratov K, Kornilova E (2005) Two different stages of epidermal growth factor (EGF) receptor endocytosis are sensitive to free ubiquitin depletion produced by proteasome inhibitor MG132. Cell Biology International. Available: http://www.cellbiolint.org/cbi/030/0031/cbi0300031.htm. Accessed 10 July 2012.